These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1354760)

  • 1. L-365,260, a potent CCK-B/gastrin receptor antagonist, suppresses gastric acid secretion induced by histamine and bethanechol as well as pentagastrin in rats.
    Nishida A; Yuki H; Tsutsumi R; Miyata K; Kamato T; Ito H; Yamano M; Honda K
    Jpn J Pharmacol; 1992 Feb; 58(2):137-45. PubMed ID: 1354760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
    Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
    J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
    Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G; Ryder H; Rooker DP; Batt AR; Kendrick DA; Szelke M; Ohta M; Satoh M; Nishida A; Akuzawa S; Miyata K
    J Med Chem; 1997 Jan; 40(3):331-41. PubMed ID: 9022799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
    Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN
    Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula.
    Takemoto Y; Yuki H; Nishida A; Ito H; Kobayashi-Uchida A; Takinami Y; Akuzawa S; Ohta M; Satoh M; Semple G; Miyata K
    Arzneimittelforschung; 1998 Apr; 48(4):403-7. PubMed ID: 9608884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
    Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
    Yuki H; Nishida A; Miyake A; Ito H; Akuzawa S; Takinami Y; Takemoto Y; Miyata K
    Dig Dis Sci; 1997 Apr; 42(4):707-14. PubMed ID: 9125636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat.
    Hirst BH; Elliott KJ; Ryder H; Szelke M
    Aliment Pharmacol Ther; 1991 Feb; 5(1):31-9. PubMed ID: 1932479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of somatostatin and its analog on gastric secretion. An application of the secretagogues to gastric secretion].
    Nomura M; Nishimori T
    Nihon Yakurigaku Zasshi; 1985 Sep; 86(3):189-95. PubMed ID: 2867956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.
    Pendley CE; Fitzpatrick LR; Ewing RW; Molino BF; Martin GE
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1348-54. PubMed ID: 8510013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretagogue-specific effects of interleukin-1 on gastric acid secretion.
    Wallace JL; Cucala M; Mugridge K; Parente L
    Am J Physiol; 1991 Oct; 261(4 Pt 1):G559-64. PubMed ID: 1681735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.
    Lotti VJ; Chang RS
    Eur J Pharmacol; 1989 Mar; 162(2):273-80. PubMed ID: 2721567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of gastrin-induced gastric acid secretion by antisense oligonucleotide to the CCKB/gastrin receptor.
    Rao RK; Lopez Y; Lai J; Riviere PJ; Junien JL; Porreca F
    Neuroreport; 1995 Nov; 6(17):2373-7. PubMed ID: 8747156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
    Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
    Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
    Ding XQ; Håkanson R
    Pharmacol Toxicol; 1996 Dec; 79(6):324-30. PubMed ID: 9000260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cimetidine on stimulated gastric secretion and serum gastrin in the dog.
    Hirschowitz BI; Gibson RG
    Am J Gastroenterol; 1978 Nov; 70(5):437-47. PubMed ID: 369358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
    Oiry C; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
    Eur J Pharmacol; 1995 Dec; 294(2-3):511-9. PubMed ID: 8750713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin.
    Corwin RL; Smith GP
    Peptides; 1993; 14(2):253-7. PubMed ID: 8483804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.